GCMNs expressing PD‐1 can actively target PD‐L1 on the surface of cancer cells and prevent PD‐1–PD‐L1 signaling between T cells and cancer cells, revitalizing T cells and eradicating cancer cells. Here, PDCD1 is linked to cancer.